Body Handbook კატალოგი პროფილი რეიტინგი
ჯანდაცვა BODY HANDBOOK
ჯანდაცვა · §622
Fluoroquinolone Antibiotics
Cipro, Levaquin, and Avelox are fluoroquinolones, a common antibiotic most people meet as a prescription for a urinary tract or sinus infection. They cure the infection. They also rupture tendons, thin the wall of the aorta, damage nerves, and swing brain chemistry, sometimes from a single 5-day course, sometimes for good. The FDA stacked four black-box warnings on the label and Europe restricted the whole class EMA 2019. For the everyday infections it gets handed out for, safer drugs work just as well.
აარიდე · საჭიროებისამებრ მტკიცებულება ძლიერი თავი ჯანდაცვა

Fluoroquinolones kill bacteria by jamming the enzymes they use to copy their DNA 1. At the same dose, the drug also nicks a related enzyme inside human mitochondria, your cells' energy plants 2. That side hit is why this class behaves less like an antibiotic and more like a connective-tissue and nerve toxin.

Four harms earned the black boxes. Tendon rupture is the biggest signal: current users run roughly triple the Achilles-rupture rate, concentrated over age 60 3. Add an oral steroid and the rate climbs about nine-fold on top of that 4. Aortic aneurysm and dissection follows the same collagen-damaging signature 5. Peripheral neuropathy shows up as tingling and numbness in hands and feet, days into a course and sometimes permanent 6. Nervous-system effects run from insomnia and anxiety through agitation and, rarely, seizures 7.

A small group develops a lasting multi-system syndrome after a single short course, now named fluoroquinolone-associated disability 8. No test flags who is susceptible beforehand.

When one is offered, ask by name what else would work. Declining costs you nothing if the alternative clears the infection, and for routine outpatient use it usually does.

What you're rolling for. For most people the course finishes and nothing else happens; the harm lives in the tail. Roughly 1 to 5 prescriptions per 10,000 produce a tendon rupture in the general population, more on a steroid, and the small minority with the persistent syndrome may carry it for years 9. That looks like a snapped Achilles on a normal jog three weeks later, or numb feet that don't recover. None of it would matter if the drug were irreplaceable. For the everyday infection, it isn't.

The fine print — when to skip it, and what people get wrong

It is not "just another antibiotic": no other outpatient class carries a stacked black box, and the harms hit 5-day courses as readily as long ones 10.

Hard contraindications: myasthenia gravis, known aortic disease, Marfan or Ehlers-Danlos, or a prior reaction to one 11. If you do take it, keep it 2 hours from any calcium, iron, or multivitamin, which neutralize the dose 12.

References
  1. 1Aldred KJ, Kerns RJ, Osheroff N (2014). Mechanism of quinolone action and resistance. Biochemistry. link
  2. 2Hangas A, Aasumets K, Kekäläinen NJ, et al. (2018). Ciprofloxacin impairs mitochondrial DNA replication initiation through inhibition of Topoisomerase 2. Nucleic Acids Research. link
  3. 3Sode J, Obel N, Hallas J, Lassen A (2007). Use of fluoroquinolone and risk of Achilles tendon rupture: a population-based cohort study. European Journal of Clinical Pharmacology. link
  4. 4Persson R, Jick S (2019). Clinical implications of the association between fluoroquinolones and tendon rupture: the magnitude of the effect with and without corticosteroids. British Journal of Clinical Pharmacology. link
  5. 5Lee CC, Lee MT, Chen YS, et al. (2015). Risk of aortic dissection and aortic aneurysm in patients taking oral fluoroquinolone. JAMA Internal Medicine. link
  6. 6Etminan M, Brophy JM, Samii A (2014). Oral fluoroquinolone use and risk of peripheral neuropathy: a pharmacoepidemiologic study. Neurology. link
  7. 7FDA (2016). FDA Drug Safety Communication: FDA updates warnings for oral and injectable fluoroquinolone antibiotics due to disabling side effects. link
  8. 8Michalak K, Sobolewska-Wlodarczyk A, Wlodarczyk M, et al. (2017). Treatment of the fluoroquinolone-associated disability: the pathobiochemical implications. Oxidative Medicine and Cellular Longevity. link
  9. 9Daneman N, Lu H, Redelmeier DA (2015). Fluoroquinolones and collagen associated severe adverse events: a longitudinal cohort study. BMJ Open. link
  10. 10Khaliq Y, Zhanel GG (2003). Fluoroquinolone-associated tendinopathy: a critical review of the literature. Clinical Infectious Diseases. link
  11. 11FDA (2018). FDA warns about increased risk of ruptures or tears in the aorta blood vessel with fluoroquinolone antibiotics in certain patients. link
  12. 12Stahlmann R, Lode H (2010). Safety considerations of fluoroquinolones in the elderly: an update. Drugs & Aging. link
·
622